EULAR HPR: The EULAR Health Professionals Research Grant

General Information

• Every year EULAR funds one Health Professional Research project in the field of rheumatic and musculoskeletal diseases (RMD). This project should be in line with the mission, objectives, and goals of EULAR. Projects will be funded up to a maximum of EUR 30,000. 

• Relevance for EULAR HPRs should include a measurable impact of the results of the project on HPRs’ practices in at least 3 countries.

• Relevance for EULAR HPRs should preferably include more than one profession.

• Recipients of a research grant must submit a mid-term report to the Scientific Subcommittee of the EULAR HPR on the progress of the research project.

• After completion of the project the recipients must provide a written report to the EULAR Executive Committee on the results achieved. Furthermore, the recipients are expected to present their project in the EULAR HPR newsletter and may be invited to present their findings at the EULAR European Congress of Rheumatology.

Announcement

Information on the EULAR HPR research grant and the application process will be disseminated in the following ways:

• EULAR website, permanently with information updated every year and news section.

• Active announcement once a year by e-mail at least six weeks prior to the closing date of the application to:

  • Members of the HPR Committee and subcommittees.

  • Members of the HPR Assembly, other than members of the HPR Committee and subcommittees

 

Application Process

• Applicants must complete the official application form, including detailed budget (Enclosure 1), and include the full CV of the project leader as well as a project plan

• Each application will be evaluated by two members of the Scientific Sub-committee of the EULAR HPR using a standard evaluation form.

• Applicants will be informed about the decision by e-mail.

 

Evaluation critieria

• HPR project leader (EULAR HPR definition does not include medical doctors) with experience and academic credentials of relevance to the proposed study. Preference will be given to investigators/main applicants who are less advanced in their research careers. We recommend more experienced researchers to take on senior positions in the project consortium.

• Involvement of at least three European countries (even if with different levels of involvement, i.e. different tasks).

• Relation to ongoing EULAR projects in the same area is clearly described, if applicable

• Quality of the work plan, including background and rationale, accuracy of study aims and research questions, design and methodology.
• Overall scientific value.
• Relevance for EULAR HPRs:
• Practice: Impact on HPRs’ management of people with RMDs in at least 3 countries, from a short and/or long-term perspective,
• Research: Impact on future research related to HPRs’ management of people with RMDs and/or whether the project may foster the development of a research network of relevance for the future beyond the period of the project.
• Realistic plan for dissemination and implementation of the research results among clinicians and researchers

• Patient centered approach and inclusion of the perspective of patient representatives

• Feasibility of the study within the planned time frame

• Budget realistic for the planned project

 

Approval by EULAR Council

After evaluation by HPR Scientific Subcommittee members, a report on the selection procedure and the selected project proposal and accompanying review forms and the final decision will be submitted to the EULAR Council.

Time Schedule 

Activity	Frequency and Duration	Time Schedule
Review of website content regarding Research Grant	Once, yearly (after closure of application)	15 January
Active announcement of Research Grant	Once, yearly (at least six weeks prior to the application deadline)	1 October
Application Deadline	Once, yearly	15 December
Review of Applications	Once, yearly (max duration, 4 weeks)	10 January
Summary of review, feedback to be sent to applicants (when the decision is approved), and selection of proposal	Once, yearly (max duration, 2 weeks)	31 January
Submission of selected proposal to EULAR Council	Once, yearly	31 January
Approval of selected proposal	Once, yearly, by the HPR Representation Committee (the decision will presented to the EULAR Council during the March Meeting)	March